LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.
暂无分享,去创建一个
Z. Liu | S. Ouyang | W. Kuang | H. Wu | Y. Tian | Yongquan Tian | Wei-Lu Kuang
[1] Meng Jin,et al. MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells , 2018, Experimental and therapeutic medicine.
[2] Jing‐ying Hou,et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p , 2018, Stem Cell Research & Therapy.
[3] H. Zhang,et al. Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma. , 2018, Gene.
[4] C. Piperi,et al. Emerging role of plexins signaling in glioma progression and therapy. , 2018, Cancer letters.
[5] Jian Zheng,et al. The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis , 2018, Front. Mol. Neurosci..
[6] Nan Tian,et al. Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles. , 2017, American journal of translational research.
[7] Yan Peng,et al. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway , 2017, Oncotarget.
[8] Tao Chen,et al. MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma , 2017, Experimental and therapeutic medicine.
[9] Dan-dan Wang,et al. MiR-138: A promising therapeutic target for cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[10] Liang Zhou,et al. MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[11] F. Yamaguchi. Therapy Decisions for Patients with High-Grade Glioma and Their Families. , 2017, World neurosurgery.
[12] Shanshan Liu,et al. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC–p53 protein interactions , 2017, EMBO reports.
[13] H. Cai,et al. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma , 2017, Oncogene.
[14] J. Cell. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017 .
[15] Qiang Liu,et al. Different expression of miR-29b and VEGFA in glioma , 2016, Artificial cells, nanomedicine, and biotechnology.
[16] Cheng Qiu,et al. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis , 2016, Oncotarget.
[17] M. Davis. Glioblastoma: Overview of Disease and Treatment. , 2016, Clinical journal of oncology nursing.
[18] M. Affolter,et al. Cell behaviors and dynamics during angiogenesis , 2016, Development.
[19] W. Wick,et al. Current status and future directions of anti-angiogenic therapy for gliomas. , 2016, Neuro-oncology.
[20] H. Xia,et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. , 2016, Journal of neurosurgery.
[21] A. Hochberg,et al. The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory , 2015, Molecular Cancer.
[22] A. Reynolds,et al. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions , 2014, Angiogenesis.
[23] Nina Kočevar,et al. Glioma and glioblastoma - how much do we (not) know? , 2013, Molecular and clinical oncology.
[24] G. Semenza. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.
[25] M. Shibuya. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. , 2011, Genes & cancer.
[26] P. Fagenholz,et al. Hypoxia and inflammation. , 2011, The New England journal of medicine.
[27] Xiaoyuan Chen,et al. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. , 2010, Current drug targets.
[28] Chi-Tang Ho,et al. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. , 2009, Carcinogenesis.
[29] Igor Jurisica,et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. , 2006, Cancer research.
[30] J. Block,et al. Hypoxia induces HIF‐1α and VEGF expression in chondrosarcoma cells and chondrocytes , 2004 .
[31] S. Negrotto,et al. [Angiogenesis in cancer]. , 2002, Medicina.
[32] H. Verheul,et al. The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors. , 2000, Clinical breast cancer.